Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ASPH | Q12797 | 1/20 | 0.39 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6215307 | 0.86 | TDP1 (0.50) | TDP1MAPTCES2CES1MEP1B | |
| SCHEMBL116280 | 0.85 | CES2 (0.45) | TDP1MAPTCES2CES1MEP1B | |
| SCHEMBL12756987 | 0.85 | TDP1 (0.49) | TDP1MAPTCES2CES1MEP1B | |
| SCHEMBL1766176 | 0.83 | MAPT (0.66) | TDP1MAPTALDH1A1HTTLMNA | |
| SCHEMBL201535 | 0.83 | CES2 (0.44) | TDP1MAPTCES2CES1MEP1B | |
| SCHEMBL3808483 | 0.83 | CES2 (0.48) | MAPTCES2CES1MEP1BALDH1A1 | |
| SCHEMBL21262467 | 0.83 | TDP1 (0.66) | TDP1MAPTCES2CES1ALDH1A1 | |
| SCHEMBL24918 | 0.83 | CES2 (0.44) | TDP1MAPTCES2CES1MEP1B | |
| SCHEMBL2925986 | 0.81 | ALDH1A1 (0.58) | TDP1MAPTMEP1BALDH1A1HSD17B10 | |
| SCHEMBL6693436 | 0.81 | KDM4E (0.49) | TDP1MAPTCES2CES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079887-A | Preparation method of nemonoxacin key intermediate | — | 2026-05-26 | — | — | CN | claimed |
| CN-114106304-A | Low-temperature curing weather-resistant polyester resin, low-temperature curing weather-resistant powder coating and preparation method | 安徽神剑新材料股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-111530390-B | Continuous production device and method of 2, 4-difluoro-3-methoxybenzoic acid | 台州学院 | 2020-12-15 | — | — | CN | claimed |
| CN-111530390-A | Continuous production device and method of 2, 4-difluoro-3-methoxybenzoic acid | 台州学院 | 2020-08-14 | — | — | CN | claimed |
| CN-101298418-A | Preparation method of 3-oxo-3- (2, 4-dihalogen-3-difluoromethoxyphenyl) ethyl propionate | JIANGSU CHEMSPEC AGRO CHEMICAL (CN) | 2008-11-05 | — | — | CN | claimed |
| CN-122079887-A | Preparation method of nemonoxacin key intermediate | — | 2026-05-26 | — | — | CN | disclosed |
| US-20250250269-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. | 2025-08-07 | — | — | US | disclosed |
| CN-120423943-A | Preparation method of 2, 4-difluoro-3-methoxybenzoic acid | 苏州科伦药物研究有限公司 | 2025-08-05 | — | — | CN | disclosed |
| CN-120423943-A | Preparation method of 2, 4-difluoro-3-methoxybenzoic acid | 苏州科伦药物研究有限公司 | 2025-08-05 | — | — | CN | disclosed |
| CN-120136692-A | Synthesis method of nemonoxacin malate intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119528713-A | Synthesis method of nemonoxacin intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-4508047-A1 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-1015445-A1 | ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999058521-A1 | 11-ARYL-BENZO[B]NAPHTHO[2,3-D]FURANS AND 11-ARYL-BENZO[B]NAPHTHO[2,3-D]THIOPHENES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999048851-A2 | PROCESSES FOR PREPARING INTERMEDIATES | AVENTIS CROPSCIENCE S.A. (FR) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999035117-A1 | PROCESS FOR MAKING CERTAIN BENZOIC ACID COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1999014214-A1 | ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5886016-A | ANTIINFLAMMATORY AGENT WITH MINIMAL SIDE EFFECTS FOR TREATING ARTHRITIS | G.D. SEARLE & CO. (US) | 1999-03-23 | — | — | US | disclosed |
| WO-1998051153-A1 | HERBICIDAL METHODS AND DERIVATIVES | RHONE-POULENC AGRICULTURE LTD. (GB) | 1998-11-19 | — | — | WO | disclosed |
| WO-1996009304-A1 | BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250269-A1 | HETEROCYCLIC GLP-1 AGONISTS | GLP1R, GIPR, IAPP | TDP1 2422/4885MAPT 3395/4885CES2 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.